Zhu PL, Lam DF, Li JK, Fu XQ, Yin CL, Chou JY, et al
So, now, we have several medications in the class of GLP-1 agonists designed for diabetes and some specifically designed for weight loss (even though they are exactly the same and just differ in dosing)
Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects
Recently, Galderma, the makers of Sculptra and Restylane, completed a landmark 9-month Phase IV clinical trialthe first study evaluating Sculptra combined with HA fillers specifically for GLP-1related volume loss
This type of medication works by preventing bacteria from multiplying or by killing them
How to Properly Dispose of Medical Sharps: Place your sharps in a non-puncturable container